We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Centauri Therapeutics Ltd closes £2.5m fundraising

News   Feb 23, 2017 | Original Story From Centauri Therapeutics

 
Centauri Therapeutics Ltd closes £2.5m fundraising
 
 
 

RELATED ARTICLES

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

Vaccine Drives Antibodies to Target Tau Tangles in Mice

News

A vaccine pioneered by virus-like particles induced a robust and long-lived antibody response to tau protein in mice, reducing soluble and insoluble species of Tau in the hippocampus and cortex.

READ MORE

World’s First Reported Spontaneous Clearance of HIV, Without Treatment

News

In 1981, a patient from Sydney was transfused with a weakened form of HIV-1 when he received a blood transfusion following a motorbike accident. After controlling his infection for more than 30 years, he appears to have cleared his infection altogether – without therapy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE